Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

Completed · Not applicable

Conditions studied: Osteoarthritis

In brief

safety, efficacy and acceptability of Flavocoxid

Key facts

Study ID

NCT00303017

Run by

Primus Pharmaceuticals

People needed

60

Starts

2006-03-01

Expected to finish

2006-09-01

Last updated by the study team

2015-10-21

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• OA of the knee,K-L grade 2-3 in general good health is currently taking an NSAID or COX-2 inhibitor -

You may not qualify if…

• pregant or nursing women grade 1 or 4 OA any significant medical condition that in the opinion of the physician might put the subject at risk in this study any form of arthropathy other than OA any condition that might confound the evaluation of the pain, stiffness or function of the target joint intra-articular cotticosteroid inkection in the target joint within 3 month of the screening visit concomitant use of other anti-inflammatory or anti arthritic medication or products(including OTC and herbal preparations) Low dose aspirin for cardio-protection is allowed concomitant use of coumadin or other anticoagulant or anti-platelet medication concomitant use of gastro-protectiv medications including, but not limited to, H2 blockers and proton pump inhibitors, including OTC and herbal products History of allergy to Flavonoids

Where it is running

• Timothy Truitt MD — Melbourne, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.